Results
1 -
10 of
25Metabolism of carteolol by cDNA-expressed human cytochrome P450, European Journal of Clinical Pharmacology Pharmacokinetics of the warfarin enantiomers in rats, Journal of Pharmacokinetics and Biopharmaceutics Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes, European Journal of Clinical Pharmacology Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin, European Journal of Clinical Pharmacology Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man, European Journal of Clinical Pharmacology Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes, European Journal of Clinical Pharmacology Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults, Advances in Therapy The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose, European Journal of Clinical Pharmacology Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole, Digestive Diseases and Sciences Workshop: Warfarin drug interactions: Detection, prediction, prevention, Journal of Thrombosis and Thrombolysis